A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4 + T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256

Autor:	Wilkin, Timothy J., Lalama, Christina M., McKinnon, John, Gandhi, Rajesh T., Lin, Nina, Landay, Alan, Ribaudo, Heather, Fox, Lawrence, Currier, Judith S., Mellors, John W., Gulick, Roy, Tenorio, Allan R.
Zdroj:	The Journal of Infectious Diseases, 2012 Aug . 206(4), 534-542.
Databáze:	JSTOR Journals
Externí odkaz:	http://dx.doi.org/10.1093/infdis/jis376 Zobrazit plný text záznamu